Robot-Assisted Transmesocolic Retroperitoneal Lymphadenectomy in Testicular Non-Seminomatous Germ Cell Tumors: A Promising Approach.
Testicular cancer accounts for 5% of urological tumors, with an incidence of 5.6 cases per 100,000 men per year in Europe (1). Salvage retroperitoneal lymphadenectomy is the standard surgery for persistent retroperitoneal masses after chemotherapy.